Zobrazeno 1 - 10
of 35 514
pro vyhledávání: '"Leukemia lymphocytic chronic"'
Autor:
Zhang J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Ma J; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Li Y; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China., Lv X; Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China., Feng L; Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2403203. Date of Electronic Publication: 2024 Sep 18.
Autor:
Vijenthira A; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada., Volpe VO; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Sekar A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Santos Azevedo R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mikhaleva M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Martindale SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fardoun R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tyekucheva S; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA., Ren Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Knisbacher BA; The Mina and Everard Goodman Faculty of Life Sciences, Ramat Gan, Israel.; Broad Institute of MIT and Harvard, Cambridge, MA., Hahn CK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Getz G; Department of Medicine, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA.; Krantz Family Center for Cancer Research and Dept. of Pathology, Massachusetts General Hospital, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Dec 10; Vol. 8 (23), pp. 5949-5956.
Autor:
Svozilova H; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Vojtova L; Advanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Matulova J; Advanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Bruknerova J; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Polakova V; Advanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic., Radova L; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Doubek M; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Plevova K; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Pospisilova S; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Internal Medicine-Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Institute of Medical Genetics and Genomics, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Publikováno v:
PeerJ [PeerJ] 2024 Dec 06; Vol. 12, pp. e18637. Date of Electronic Publication: 2024 Dec 06 (Print Publication: 2024).
Autor:
Tausch E; Comprehensive Cancer Center Ulm and Division of CLL-Internal Medicine III, Ulm University, Germany., Schneider C; Comprehensive Cancer Center Ulm and Division of CLL-Internal Medicine III, Ulm University, Germany., Stilgenbauer S; Comprehensive Cancer Center Ulm and Division of CLL-Internal Medicine III, Ulm University, Germany.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 457-466.
Autor:
Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Siddiqi T; Department of Hematology/Hematopoietic Cell Transplantation, City of Hope Orange County, Irvine, CA.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 474-481.
Autor:
Rogers KA; Division of Hematology, The Ohio State University, Columbus, OH., Woyach JA; Division of Hematology, The Ohio State University, Columbus, OH.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2024 Dec 06; Vol. 2024 (1), pp. 467-473.
Autor:
Zhao X; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Bian H; Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Hao F; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Shao S; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shangdong, China., Wu C; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Zhang Q; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Wu M; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Li Z; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China., Gao C; Laboratory of Medical Biology, Medical Research Center, The Affiliated Hospital of Qingdao University and The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao, Shangdong, China.
Publikováno v:
Annals of medicine [Ann Med] 2024 Dec; Vol. 56 (1), pp. 2419556. Date of Electronic Publication: 2024 Oct 26.
Autor:
Ehrmann AS; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Mechanisms of Leukemogenesis (B061), German Cancer Research Center (DKFZ), Heidelberg, Germany., Zadro A; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany., Tausch E; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Comprehensive Cancer Center Ulm (CCCU), University Hospital of Ulm, Ulm, Germany., Schneider C; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Comprehensive Cancer Center Ulm (CCCU), University Hospital of Ulm, Ulm, Germany., Stilgenbauer S; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Comprehensive Cancer Center Ulm (CCCU), University Hospital of Ulm, Ulm, Germany., Mertens D; Division of CLL, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.; Mechanisms of Leukemogenesis (B061), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (13), pp. 1941-1953. Date of Electronic Publication: 2024 Aug 19.
Autor:
Fallin T; Department of Pharmacy, Clinical and Administrative Sciences, OU Health, University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA., Thacker E; Department of Pharmacy, Clinical and Administrative Sciences, OU Health, University of Oklahoma College of Pharmacy, Oklahoma City, OK, USA., Sahra S; Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Siegrist EA; Department of Pharmacy, Clinical Infectious Diseases, OU Health, Oklahoma City, OK, USA., White BP; Department of Pharmacy, Clinical Infectious Diseases, OU Health, Oklahoma City, OK, USA., Summers K; Department of Pharmacy, Critical Care, OU Health, Oklahoma City, OK, USA., Shibib D; Department of Pathology, Microbiology and Virology Laboratories, OU Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Sassine J; Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Publikováno v:
Journal of pharmacy practice [J Pharm Pract] 2024 Dec; Vol. 37 (6), pp. 1391-1395. Date of Electronic Publication: 2024 Apr 15.
Autor:
Bauvois B; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, F-75006, Paris, France. Electronic address: brigitte.bauvois@sorbonne-universite.fr., Nguyen-Khac F; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, F-75006, Paris, France; Sorbonne Université, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Service d'Hématologie Biologique, F-75013, Paris, France. Electronic address: florence.nguyen-khac@aphp.fr., Merle-Béral H; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, F-75006, Paris, France. Electronic address: helenemerleberal@gmail.com., Susin SA; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, F-75006, Paris, France. Electronic address: santos.susin@sorbonne-universite.fr.
Publikováno v:
Biochimie [Biochimie] 2024 Dec; Vol. 227 (Pt A), pp. 135-151. Date of Electronic Publication: 2024 Jul 14.